Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults

Clinical trial NCT02142504 · COMPLETED

Trial details

NCT number: NCT02142504
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Norovirus Prevention

Start date: 2014-05-15
Primary completion: 2016-01-06
Enrollment: 454

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.